Učitavanje...
Alemtuzumab Induction and Tacrolimus Monotherapy in Pancreas Transplantation: One- and Two-Year Outcomes
BACKGROUND: Alemtuzumab (Campath-1H) induction with tacrolimus monotherapy has been shown to provide effective immunosuppression for kidney, liver, lung, and small bowel transplantation. This drug combination was evaluated in pancreas transplant recipients. METHODS: Sixty consecutive pancreas transp...
Spremljeno u:
| Glavni autori: | , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2006
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2952504/ https://ncbi.nlm.nih.gov/pubmed/17198247 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/01.tp.0000250712.12389.3d |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|